v3.25.1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Statement of Comprehensive Income [Abstract]    
Net earnings $ 1,289 $ 1,372
Foreign currency translation adjustments, net of tax expense (benefit) of $17 for the three months ended March 31, 2025 and $(20) for the three months ended March 31, 2024 487 (396)
Net investment hedging activities, net of tax expense (benefit) of $(77) for the three months ended March 31, 2025 and $57 for the three months ended March 31, 2024 (283) 207
Pension and post-employment benefits, net of tax expense (benefit) of $0 for the three months ended March 31, 2025 and $1 for the three months ended March 31, 2024 (2) 10
Cash flow hedging activities, net of tax expense (benefit) of $(4) for the three months ended March 31, 2025 and $7 for the three months ended March 31, 2024 (19) 30
Other comprehensive income (loss) 183 (149)
Comprehensive income 1,472 1,223
Comprehensive income attributable to noncontrolling interest 3 3
Comprehensive income attributable to AbbVie Inc. $ 1,469 $ 1,220